Physitrack PLC Cash Flow Conversion Efficiency
Physitrack PLC cash flow conversion efficiency. Based on the latest financial reports, Physitrack PLC (PTRK) has a cash flow conversion efficiency ratio of 0.060x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr597.76K ≈ $64.33K USD) by net assets (Skr9.90 Million ≈ $1.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Physitrack PLC (2017–2025)
Cash flow conversion efficiency of Physitrack PLC from 2017 to 2025. This chart illustrates how Physitrack PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Physitrack PLC share price for real-time trading data and today's change.
Physitrack PLC Cash Flow Conversion Ratio Explained
Physitrack PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Physitrack PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Physitrack PLC ranked by their cash flow conversion efficiency. Also see PTRK market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sogn Sparebank
OL:SOGN
|
-0.002x |
|
Bodycote PLC
LSE:BOY
|
0.096x |
|
ODTech Co. Ltd
KQ:080520
|
-0.012x |
|
Camplify Holdings Ltd
AU:CHL
|
-0.067x |
|
Mongolia Growth Group Ltd.
V:YAK
|
0.080x |
|
Eterindo Wahanatama Tbk
JK:ETWA
|
0.003x |
|
Liberty TripAdvisor Holdings, Inc
NASDAQ:LTRPA
|
-0.012x |
|
Shandong Chenming Paper Holdings Limited
F:SCD1
|
0.823x |
Annual Cash Flow Conversion Efficiency for Physitrack PLC (2017–2025)
The table below shows the annual cash flow conversion efficiency of Physitrack PLC from 2017 to 2025. Review PTRK free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-11-30 | Skr9.92 Million ≈ $1.07 Million |
Skr3.88 Million ≈ $417.72K |
0.391x | +139.87% |
| 2024-11-30 | Skr19.17 Million ≈ $2.06 Million |
Skr3.13 Million ≈ $336.50K |
0.163x | +57.55% |
| 2023-11-30 | Skr25.57 Million ≈ $2.75 Million |
Skr2.65 Million ≈ $284.98K |
0.104x | +59.58% |
| 2022-11-30 | Skr22.37 Million ≈ $2.41 Million |
Skr1.45 Million ≈ $156.22K |
0.065x | +181.76% |
| 2021-11-30 | Skr28.65 Million ≈ $3.08 Million |
Skr659.81K ≈ $71.01K |
0.023x | -94.12% |
| 2020-11-30 | Skr5.19 Million ≈ $558.20K |
Skr2.03 Million ≈ $218.73K |
0.392x | -19.70% |
| 2019-11-30 | Skr1.03 Million ≈ $110.46K |
Skr500.89K ≈ $53.90K |
0.488x | -17.54% |
| 2018-11-30 | Skr1.19 Million ≈ $128.31K |
Skr705.60K ≈ $75.93K |
0.592x | +45.95% |
| 2017-11-30 | Skr1.35 Million ≈ $145.78K |
Skr549.27K ≈ $59.11K |
0.405x | -- |
About Physitrack PLC
Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehe… Read more